Latest Leadership Change News

KMD Brands reported a challenging FY25 with a net loss but has launched a transformative ‘Next Level’ strategy focused on cost reset, product innovation, and digital growth. Early FY26 trading shows promising sales momentum, signaling potential turnaround.

Golden Mile Resources announces the immediate resignation of Managing Director Damon Dormer, with the board stepping in to manage operations during the transition.

AVADA Group reported a 10.5% revenue decline in FY2025 amid operational consolidation and leadership changes, while conducting a strategic review of its New Zealand operations. Despite setbacks, the company remains cautiously optimistic about future growth.

Middle Island Resources announces the immediate resignation of CEO Roland Bartsch, with the company opting to pay out his full notice period and his unlisted options lapsing as per contract terms.

James Hardie Industries has appointed Ryan Lada as its new Chief Financial Officer, succeeding Rachel Wilson who will remain as an advisor during the transition. The move comes alongside the company’s Q2 FY26 results announcement.

James Hardie Industries has appointed Nigel Stein as the new Chair of its Board and established an Integration and Performance Committee to oversee the AZEK acquisition integration and enhance shareholder engagement.

ALS Limited has reported a robust first half for FY26, with revenue climbing 13.3% to $1.7 billion and underlying NPAT rising 17.2%, driven by strong organic growth across all business streams and strategic investments in digital innovation.

ALS Limited has posted a robust first half for FY26 with underlying EBIT growth of 14.7%, driven by strong performance in its Commodities segment and improved Life Sciences results. The company also raised its interim dividend and updated its growth outlook for the year.

Argent BioPharma has locked in an A$11 million convertible financing facility to finalize its strategic acquisition of AusCann assets and accelerate its growth plans, including a potential US stock exchange listing.

Orcoda Limited announces a pivotal leadership transition with Patrick Bodegraven stepping in as Managing Director, while long-serving Geoff Jamieson shifts to a part-time CFO role to support continuity.

Genetic Signatures Limited unveiled a year of strategic transformation and robust financial growth at its 2025 AGM, highlighting leadership renewal and a sharpened commercial focus. The company’s FY25 revenue jumped 66%, driven by strong product demand and expanded market presence.

Navigator Global Investments appoints Roger Davis as new Chair and suspends dividends to prioritize capital for growth and new partnerships.